Shares of Bausch Health, Inc. (BHC) gained 14.7% in a week on reports of refinancing its debt to enable the impending sale of its eye care company, Bausch + Lomb (BLCO) . The industry declined 0.6% during this timeframe. The sale, intended to separate both companies, is stuck for quite some time now. Hence, reports of BHC moving forward have encouraged investors. Image Source: Zacks Investment Research BHC's Plans to Separate BLCO In August 2020, BHC announced its plan to separate its eye health business, c ...